ENvue Medical, Inc. (FEED) stock
FEEDOTCOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
$0.50+0.13 (+34.73%)
Close on Oct 19, 2026Market cap $3.08MP/E –Yield –
ENvue Medical cash
Cash and short-term investments held at the end of each period.
ENvue Medical's cash was $1.08M at Jun 30, 2026. For fiscal 2025 it was $4.22M, up 461.7% from the year before. Over ten years it grew 10.1% a year on average. The highest annual figure on record is $7.74M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.22M | +461.7% |
| FY2024 | Dec 31, 2024 | $752.00K | -77.1% |
| FY2023 | Dec 31, 2023 | $3.28M | +21.0% |
| FY2022 | Dec 31, 2022 | $2.71M | -64.9% |
| FY2021 | Dec 31, 2021 | $7.74M | +8.3% |
| FY2020 | Dec 31, 2020 | $7.14M | +433.8% |
| FY2019 | Dec 31, 2019 | $1.34M | +49.3% |
| FY2018 | Dec 31, 2018 | $896.00K | -79.4% |
| FY2017 | Dec 31, 2017 | $4.36M | +4013.2% |
| FY2016 | Dec 31, 2016 | $106.00K | -93.4% |
| FY2015 | Dec 31, 2015 | $1.61M | +1693.3% |
| FY2014 | Dec 31, 2014 | $90.00K | -4.3% |
| FY2013 | Dec 31, 2013 | $94.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.08M | -73.1% |
| Q1 FY2026 | Mar 31, 2026 | $2.24M | +291.4% |
| Q4 FY2025 | Dec 31, 2025 | $4.22M | +461.7% |
| Q3 FY2025 | Sep 30, 2025 | $6.95M | +432.6% |
| Q2 FY2025 | Jun 30, 2025 | $4.03M | +85.7% |
| Q1 FY2025 | Mar 31, 2025 | $571.00K | -78.9% |
| Q4 FY2024 | Dec 31, 2024 | $752.00K | -77.1% |
| Q3 FY2024 | Sep 30, 2024 | $1.31M | -65.5% |
| Q2 FY2024 | Jun 30, 2024 | $2.17M | +757.7% |
| Q1 FY2024 | Mar 31, 2024 | $2.70M | +78.6% |
| Q4 FY2023 | Dec 31, 2023 | $3.28M | +21.0% |
| Q3 FY2023 | Sep 30, 2023 | $3.79M | +92.0% |
| Q2 FY2023 | Jun 30, 2023 | $253.00K | -93.6% |
| Q1 FY2023 | Mar 31, 2023 | $1.51M | -74.8% |
| Q4 FY2022 | Dec 31, 2022 | $2.71M | -64.9% |
| Q3 FY2022 | Sep 30, 2022 | $1.97M | -77.1% |
| Q2 FY2022 | Jun 30, 2022 | $3.94M | -30.5% |
| Q1 FY2022 | Mar 31, 2022 | $5.99M | -24.7% |
| Q4 FY2021 | Dec 31, 2021 | $7.74M | +8.3% |
| Q3 FY2021 | Sep 30, 2021 | $8.60M | +170.3% |
| Q2 FY2021 | Jun 30, 2021 | $5.67M | +5998.9% |
| Q1 FY2021 | Mar 31, 2021 | $7.95M | +494.4% |
| Q4 FY2020 | Dec 31, 2020 | $7.14M | +216.3% |
| Q3 FY2020 | Sep 30, 2020 | $3.18M | +34.2% |
| Q1 FY2020 | Mar 31, 2020 | $93.00K | -49.5% |
| Q4 FY2019 | Dec 31, 2019 | $1.34M | +49.3% |
| Q3 FY2019 | Sep 30, 2019 | $2.26M | +30.7% |
| Q2 FY2019 | Jun 30, 2019 | $2.37M | -5.7% |
| Q1 FY2019 | Mar 31, 2019 | $184.00K | -94.7% |
| Q4 FY2018 | Dec 31, 2018 | $896.00K | -79.4% |
| Q3 FY2018 | Sep 30, 2018 | $1.73M | +2006.1% |
| Q2 FY2018 | Jun 30, 2018 | $2.52M | +1069.8% |
| Q1 FY2018 | Mar 31, 2018 | $3.49M | +6745.1% |
| Q4 FY2017 | Dec 31, 2017 | $4.36M | +4013.2% |
| Q3 FY2017 | Sep 30, 2017 | $82.00K | -89.7% |
| Q2 FY2017 | Jun 30, 2017 | $215.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $51.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $106.00K | – |
| Q2 FY2016 | Jun 30, 2016 | $799.00K | – |
See a number that looks wrong?